Overview

Leveraging on our certified central laboratory as well as Singapore’s established healthcare system, we focus on life science technologies that can be translated and commercialized into laboratory-developed tests (LDT) or point-of-care tests (POCT) for Southeast Asian market.

Our central laboratory in Singapore serves as a testing hub for Southeast Asia. Together with our partners in the healthcare sector, we believe that we can be an anchor point to validate, test, and roll out innovative technologies for commercialization in Southeast Asia.

Consultation

Market study

  • UK
  • India
  • China
  • Southeast Asia

Regulatory support

  • Singapore
  • China

Distribution strategy

  • XXX
Clinical validation

Clinical validation

Contract research

Contract research

Commercialization

Commercialization